COPD

January 21, 2015November 10, 2015

Lung Transplant Recipients from Donors Who Drink Heavily are at Higher Risk of Lung Complications

COPD, News

According to new research from the Loyola University Medical Center, recipients of lung donors with a heavy alcohol use history are at higher risk of developing severe primary graft dysfunction ... Read more

January 20, 2015November 10, 2015

New Study Design To Test Novel COPD Drug

COPD, News

Researchers from Germany recently designed a longitudinal prospective non-intervention study (DACCORD) aimed at assessing the efficacy of a new drug called long-acting anticholinergic glycopyrronium bromide for the treatment of chronic ... Read more

January 20, 2015November 10, 2015

Invion Ltd. Announces Interim Data from Smoking Cessation Drug Study with INV102 (Nadolol)

COPD, News

Melbourne-based Invion Limited, a clinical-stage drug development company focused on the development of treatments for major market opportunities in inflammatory diseases including asthma, chronic bronchitis and lupus, has just announced favorable ... Read more

January 14, 2015November 10, 2015

Vitamin D Improves COPD Exacerbations in Adult Patients

COPD, News

A recent study entitled “Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomized controlled trial” reveals that Vitamin D supplements can protect against chronic obstructive ... Read more

January 12, 2015November 10, 2015

Effects of Genome-wide mRNA Expression in Patients with COPD Highlighted in New Study

COPD, News

Roberto Rabinovich from the ELEGI Colt Laboratory at the Centre for Inflammation Research in Edinburgh, identified 42 differently expressed genes involved in skeletal muscle wasting in COPD. The study entitled ... Read more

January 9, 2015November 11, 2015

Novartis Submits New Drug Applications For Two New COPD Therapies

COPD, News

Novartis submitted two New Drug Applications (NDAs) for QVA149 and NVA237 for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) to the U.S. Food and Drug Administration (FDA). ... Read more

January 9, 2015November 11, 2015

Gene Expression Study Explores Muscle Wasting in COPD Patients

COPD, News

Roberto Rabinovich from the Queen’s Medical Research Institute at the University of Edinburgh and colleagues identified 42 differently expressed genes involved in skeletal muscle wasting in COPD. The study entitled ... Read more

January 9, 2015November 11, 2015

Novartis Reveals Two COPD Drugs’ Positive Phase III Results and NDA Submission

COPD, News

Novartis recently announced robust findings from a pivotal Phase III clinical study for QVA149 (indacaterol/glycopyrronium bromide) and NVA237 (glycopyrronium bromide), meant to support these pipeline medications’ New Drug Applications with the ... Read more

January 7, 2015November 11, 2015

Vectura and Janssen Enter Global Partnership for Asthma, COPD

Asthma, COPD, News

Vectura Group, a product development company that specializes in pharmaceutical therapies for airway-related diseases, has just announced it has signed an international development and licensing agreement with Janssen Biotech, Inc., a ... Read more

January 6, 2015November 11, 2015

BioMed X and Boehringer Are Accepting Project Proposals for COPD Treatment Development

COPD, News

BioMed X Innovation Center, a unique venue for influential, emerging scientists from across the globe to come together to work on groundbreaking pre-clinical studies in the fields of biomedicine, molecular biology, cell ... Read more